During the study, it was observed that TMC offers free monthly prostate cancer screenings [33, 34] and that some TMC clinicians routinely ordered the PSA test before a medical encounter, so, during the medical encounter, they focused the conversation on the results of the pre-ordered test, instead of the discussion about participants’ risks, values, and preferences of being screened, which may hamper the application of the SDM process during the medical encounter. This evidence concerns the gene KLK3 and prostate carcinoma.